Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy at the AACR 2024 Annual Meeting | 291 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs... ► Artikel lesen | |
11.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Early Safety Data from the Company's Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy Met the Study's Initial Pre-Specified Objective | 247 | ACCESSWIRE | Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON-080 was reviewed by the study's Data Safety Monitoring Board (DSMB)The adverse event profile and tolerability... ► Artikel lesen | |
06.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
29.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers | 359 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
14.02. | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M | 1 | Seeking Alpha | ||
14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31 | 1 | Seeking Alpha | ||
14.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update | 320 | ACCESSWIRE | Successfully raised approximately $4.55 million in gross proceeds through an underwritten public offeringExtensive preclinical data on SON-1210 published in Frontiers in ImmunologyReceived approval... ► Artikel lesen | |
14.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.02. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
13.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 4 | 4.344 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS42328V8019 HELIUS... ► Artikel lesen | |
29.01. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
27.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
22.12.23 | Sonnet BioTherapeutics files for $100M mixed shelf | 6 | Seeking Alpha | ||
21.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy | 294 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 21, 2023 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
15.12.23 | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary | 4 | Reuters | ||
14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
14.12.23 | Sonnet BioTherapeutics GAAP EPS of -$18.14 beats by $9.99, revenue of $0.15M in-line | 3 | Seeking Alpha | ||
14.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update | 622 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
KRAFT HEINZ | 35,800 | -0,69 % | Kraft Natural Cheese releases line of flavor fusions: Follows the launch of Kraft Signature Shreds in March | ||
BEYOND MEAT | 5,652 | -0,28 % | Goldman looks to tap private credit markets for Beyond Meat cash | ||
MODERN PLANT BASED FOODS | 0,040 | -1,95 % | Modern Plant-Based Foods meldet Erstinteresse des weltweit meistbesuchten Themenparks und Unterhaltungskonglomerats | VANCOUVER, BC, 26. Januar 2024 / IRW-Press / Modern Plant Based Foods Inc., (CSE: MEAT) ("Modern Foods") oder (das "Unternehmen"), ein führender Anbieter in der pflanzlichen
Lebensmittelindustrie... ► Artikel lesen | |
LUCKIN COFFEE | 20,000 | 0,00 % | Luckin Coffee Inc. Announces Fourth Quarter and Full Year 2023 Financial Results | Fiscal Year 2023 Net Revenues Increased 87% More than 8,000 Net New Store Openings in Fiscal Year 2023; Ended 2023 with More than 16,200 Stores in China BEIJING, Feb. 23, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
YUM! BRANDS | 131,75 | -0,57 % | Deshalb sind Yum! Brands und McDonald's Champions für den Vermögensaufbau | Guten Tag, liebe Leserinnen und Leser,
die Restaurants kennen alle, das Unternehmen dahinter vermutlich weit weniger Menschen: Yum! Brands betreibt seit Jahrzehnten erfolgreiche Restaurantketten wie... ► Artikel lesen | |
KROGER | 51,91 | -1,10 % | Kroger Agrees With C&S For Updated Divestiture Package To Address Concerns Raised By Regulators | WASHINGTON (dpa-AFX) - The Kroger Co. (KR) and Albertsons Companies (ACI) have amended their definitive agreement with C&S Wholesale Grocers, LLC for the sale of assets in connection with their... ► Artikel lesen | |
OATLY GROUP | 0,844 | -2,99 % | Oatly Aktie: Kurssturz trotz Trendwende? | Mit einem aktuellen Kurs von 0,98 € und einem Rückgang von 1,8% in der vergangenen Woche steht Oatly, das Unternehmen für vegane Lebensmittel, vor einer Herausforderung. Der allgemeine Abkühlung des... ► Artikel lesen | |
CHIPOTLE MEXICAN GRILL | 2.808,00 | +2,73 % | Chipotle Mexican Grill Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - Chipotle Mexican Grill Inc. (CMG) released a profit for its first quarter that increased from last year and beat the Street estimates.The company's earnings totaled $359.29... ► Artikel lesen | |
VILLAGE FARMS | 1,218 | -1,62 % | Village Farms International, Inc. Expands Executive Team | ||
BLENDER BITES | 1,120 | 0,00 % | Blender Bites Ltd: Blender Bites signs distribution deal with U.S. grocer | ||
DOMINOS PIZZA INC | 452,75 | -0,67 % | Domino's (DPZ) Gears Up for Q1 Earnings: What's in Store? | ||
MAMAS CREATIONS | 5,550 | +9,47 % | Mama's Creations, Inc. - 10-K, Annual Report | ||
BARFRESH FOOD GROUP | 1,730 | +57,27 % | Barfresh Food Group Inc.: Barfresh Provides Fourth Quarter and Full Year 2023 Results and Business Update | Company Achieves Second Highest Fiscal Year Revenue in Company History Despite Restricted Supply of Smoothie Bottle Product Throughout Fiscal Year 2023 and National Carton Supply Shortage in Fourth... ► Artikel lesen | |
MCDONALDS | 257,45 | -0,43 % | Frühstück ist fertig! Jetzt ganz neu und jeden Tag von 07:00 Uhr bis 10:30 Uhr bei McDonald's | München (ots) - Ob herzhaft oder süß, vor Ort oder To Go - mit dem neuen McDonald's Frühstück ist ab sofort für jeden Geschmack was dabei! Mit einer umfassenden Erweiterung des Frühstückssortiments... ► Artikel lesen | |
SUEDZUCKER | 13,040 | -0,46 % | Südzucker: Überraschung bei der Dividende | Die vorläufigen Zahlen von Südzucker zum abgelaufenen Geschäftsjahr sind aus Sicht der Analysten der DZ Bank wenig überraschend ausgefallen. Der Umsatz liegt bei 10,3 Milliarden Euro, das EBIT kommt... ► Artikel lesen |